Covid-19 Vaccine Response in Immunocompromised Haematology Patients

NCT04805216 · clinicaltrials.gov ↗

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Covid19
Haematological Disorders
Immune Suppression

Interventions

PROCEDURE: Blood test

Sponsor

University Hospitals of North Midlands NHS Trust

Collaborators

[object Object]